Cited by

• The Tissue-Engineered Human Psoriatic Skin Substitute: A Valuable In Vitro Model to Identify Genes with Altered Expression in Lesional Psoriasis.

  Rioux G, Pouliot-Bérubé C, Simard M, Benhassine M, Soucy J, Guérin SL, Pouliot R. Rioux G, et al. Int J Mol Sci. 2018 Sep 26;19(10):2923. doi: 10.3390/ijms19102923. Int J Mol Sci. 2018. PMID: 30261611 Free PMC article.
• Development of a psoriatic-like skin inflammation rat model using imiquimod as an inducing agent.

  Parmar KM, Jagtap CS, Katare NT, Dhobi M, Prasad SK. Parmar KM, et al. Indian J Pharmacol. 2021 Mar-Apr;53(2):125-131. doi: 10.4103/ijp.IJP_506_19. Indian J Pharmacol. 2021. PMID: 34100396 Free PMC article.
• Models in the Research Process of Psoriasis.

  Bocheńska K, Smolińska E, Moskot M, Jakóbkiewicz-Banecka J, Gabig-Cimińska M. Bocheńska K, et al. Int J Mol Sci. 2017 Nov 24;18(12):2514. doi: 10.3390/ijms18122514. Int J Mol Sci. 2017. PMID: 29186769 Free PMC article. Review.
• Characterization of ZK 245186, a novel, selective glucocorticoid receptor agonist for the topical treatment of inflammatory skin diseases.

  Schäcke H, Zollner TM, Döcke WD, Rehwinkel H, Jaroch S, Skuballa W, Neuhaus R, May E, Zügel U, Asadullah K. Schäcke H, et al. Br J Pharmacol. 2009 Oct;158(4):1088-103. doi: 10.1111/j.1476-5381.2009.00238.x. Epub 2009 May 6. Br J Pharmacol. 2009. PMID: 19422381 Free PMC article.
• Bioengineered Skin Intended as In Vitro Model for Pharmacosmetics, Skin Disease Study and Environmental Skin Impact Analysis.

  Sanabria-de la Torre R, Fernández-González A, Quiñones-Vico MI, Montero-Vilchez T, Arias-Santiago S. Sanabria-de la Torre R, et al. Biomedicines. 2020 Oct 31;8(11):464. doi: 10.3390/biomedicines8110464. Biomedicines. 2020. PMID: 33142704 Free PMC article. Review.